![](/img/cover-not-exists.png)
Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
Philippe Aftimos, Ahmad AwadaVolume:
28
Language:
english
Pages:
13
DOI:
10.1007/s12325-011-0070-9
Date:
November, 2011
File:
PDF, 610 KB
english, 2011